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The mechanism of membrane disturbance by aminoglycoside antibiotics was investigated in liposomes 
containing the fluorescent probe, 1-anUino-8-naphthalene sulfonate (ANS). Liposomes of PC and different 
anionic phospholipids (1:1 to 15:1 molar ratios) were challenged with aminoglycosides in the presence of 
low (1 /~M) and high (3 raM) concentrations of calcium. Liposomes containing PIP 2 showed the greatest 
drug-induced changes in ANS fluorescence in the presence of high and low concentrations of calcium and at 
all P C : P I P  2 molar ratios tested. Liposomes containing other anionic phospholipids (PS, PI and PIP) were 
not reactive toward aminoglycosides in the presence of 3 mM calcium or when the ratio of PC to anionic 
lipid was increased to 10: 1. The aminoglycoside-induced changes of ANS fluorescence were not due to any 
changes in the emission spectrum of ANS, nor to changes in quantum yield, nor to a change in the binding 
affinity of ANS. It is concluded that a specific aminoglycoside-PIP 2 interaction results in phase separation 
of PC and PIP 2 and thus increases the number of available ANS binding sites in PC:PIP 2 iiposomes. 
Introduction 
Despite recent progress in the management of 
bacterial infections, most prominently the intro- 
duction of the powerful cephalosporins, the 
aminoglycoside antibiotics are still indispensable 
antimicrobial agents. The search for replacement 
drugs is prompted by increasing bacterial resis- 
tance and the adverse effects of the aminoglyco- 
sides on the function of the inner ear (both hear- 
ing and equilibrium) and the kidney. The efficient 
development of improved aminoglycosides and 
semi-synthetic derivatives is hampered by the 
lengthy and complex animal experiments neces- 
sary to evaluate drug-induced hearing loss. Ra- 
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tional design of new drugs would be greatly aided 
by model systems in which in-vitro correlates of 
toxicity could be tested. Recent advances in our 
understanding of aminoglycoside toxicity have en- 
abled us to propose such model systems. They are 
derived from a key reaction in the proposed 
multi-step toxic mechanism, the specific binding 
of aminoglycosides to phosphatidylinositol bis- 
phosphate (PIP2) [1]. 
In vivo experiments as well as studies with 
monolayers and liposomes as model membranes 
have demonstrated the unique nature of the inter- 
actions between aminoglycosides and PIP 2. When 
monomolecular films of L-ct-phosphatidylcholine 
mixed with various anionic phospholipids were 
challenged with aminoglycosides, only the PIP 2 
containing films showed a dose-dependent and 
toxicity-related increase in surface pressure while 
others showed a decrease or no significant effect 
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[2]. Aminoglycosides also lowered the phase tran- 
sition temperature of PIP 2 containing liposomes 
while it raised the transition temperature of all 
other anionic phospholipid-PC liposomes tested 
[3]. Since the membrane effects of a variety of 
aminoglycosides correlated well with their ototox- 
icity, these model systems showed promise both in 
elucidating molecular mechanisms and screening 
drugs for their toxic potential. A critical issue, 
however, in relating the in vitro to the in vivo 
situation was the fact that these models required 
concentrations of PIP 2 that were at least one order 
of magnitude higher than expected in the biologi- 
cal target membranes. Furthermore, these models 
were only able to document drug-induced alter- 
ations in membrane structure and fluidity without 
allowing insight into the underlying mechanisms 
at the molecular level. The present study addresses 
these two points. 
The fluorescent membrane probe, 1-anilino-8- 
naphthalene sulfonate (ANS), has been widely 
used to study structural changes induced by a 
large variety of compounds in natural and artifi- 
cial membranes [4]. ANS is noncovalently incor- 
porated into these structures and its fluorescence 
is highly sensitive to changes in the molecular 
environment of the phospholipid bilayer. Its 
negligible interference with membrane properties 
and its convenient absorption characteristics make 
ANS the fluorescent probe of choice to study 
conformational changes that occur within the 
bilayers of liposomes as a result of interactions 
with drug molecules. The resultant fluorescence 
changes can be interpreted at the molecular level 
since differences in the molecular environment of 
the probe can be easily separated from changes in 
the binding affinity or number of binding sites. 
Materials and Methods 
L-a-Phosphatidylcholine (PC, from frozen egg 
yolk), L-a-phosphatidylserine (PS), L-a-phos- 
phatidylinositol (PI) and 1-anilino-8-naphthalene 
sulfonate (magnesium salt) were purchased from 
Sigma Chemical Co., St. Louis, M.O. Gentamicin 
sulfate was supplied by the Schering Corp. 
(Bloomfield, N.J.) and amikacin by Bristol Labo- 
ratories (New York, NY). Phosphatidylinositol 4- 
phosphate (PIP) and phosphatidylinositol 4,5-bis- 
phosphate (PIP2) were isolated from Sigma brain 
extracts (Cat. No. P6023) by chromatography on 
immobilized neomycin [5]. Lipids were stored in 
the dark under nitrogen at - 2 0 ° C ;  PIP and PIP 2 
were dried and the other lipids were kept dis- 
solved in chloroform. The purity of the lipids was 
grater than 98% as estimated by thin-layer chro- 
matography. The water was thrice distilled, the 
second and third time in an all-glass apparatus. 
The buffer for all experiments was 0.05 M Hepes 
(N-2-hydroxyethyl- l -piperazine-N'-2-ethanesul-  
fonic acid), pH 7.0; ionic strength 0.2, adjusted 
with sodium chloride. All other chemicals were of 
reagent grade. 
Preparation of liposomes. Multilamellar lipo- 
somes were prepared as previously described [3] 
from PC and an anionic phospholipid at molar 
ratios ranging from 1:1  to 15:1. Aliquots of the 
chloroform solutions of the lipid mixtures were 
transferred to a 10-ml round-bottom flask. The 
solvent was evaporated under nitrogen while the 
flask was rotated by hand to aid the formation of 
a uniformly thin lipid film at its bottom. Residual 
solvent was removed by storing the flask overnight 
under vacuum. The dried lipid was then sus- 
pended in buffer and vortexed intermittently for 1 
h. The final dispersion was sonicated for two 
minutes in a bath type sonicator (Branson Clean- 
ing Equipment, Shelton, CT). 
Fluorescence experiments. Aliquots of the lipo- 
some stock suspension were incubated with vari- 
ous concentrations of ANS and calcium chloride 
or aminoglycosides or both for 60 min at room 
temperature. Incubation for more than 60 min did 
not change the results. Fluorescence was measured 
at room temperature with a Perkin-Elmer, Model 
LS-5 spectrofluorometer. The slit width was 10 nm 
for both excitation (385 nm) and emission (475 
nm). Each experiment was conducted in triplicate 
and the reproducibility was always within 3%. The 
observed fluorescence intensities of the mixtures 
were corrected for the individual fluorescence of 
the liposomes, free ANS, calcium and amino- 
glycosides. 
The molar ratio of PC to anionic lipids in the 
liposomes was varied from 1 : 1 to 15 :. Quantum 
yield, dissociation constants and number of bind- 
ing sites were determined at a molar ratio o f  4 : 1 
since this ratio proved most sensitive for quantita- 
tive studies [6]. 
R e s u l t s  
The absolute magnitude of the fluorescence of 
the ANS-treated liposomes varied with the type as 
well as with the quantity of the anionic phos- 
pholipid. These differences are due primarily to 
differences in electrostatic potentials of the lipo- 
somes [4]. In order to compare the effects of 
aminoglycosides or calcium on liposomes of dif- 
ferent lipid compositions, the fluorescence intensi- 
ties in the presence of drug ( F  i) were normalized 
to the corresponding measurement in its absence 
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(F0). It should be noted that neither calcium nor 
aminoglycosides, even at concentrations as high as 
10 mM, affected the fluorescence of ANS in lipo- 
somes of pure PC. 
Calcium at concentrations below 0.1 mM had 
very little effect on the fluorescence of ANS in 
liposomes prepared from PC and any of the 
anionic phospholipids (1 : 1 molar ratio) (Fig. 1A). 
Higher concentrations of calcium increased fluo- 
rescence of the P C / P I P  2 liposomes about 2-fold 
and this level was reached at 1 mM C a  2+. In 
contrast, liposomes containing PS, PI or PIP were 
not significantly affected by calcium even at con- 
centrations as high as 10 mM. 
The effects of gentamicin on the fluorescence 
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Fig. 1. Relative fluorescence intensity of mixed liposomes of PC and anionic phospholipids incubated with 10 ~M ANS and calcium 
chloride or gentamicin for 60 min at room temperature as described in Materials and Methods. (A) PC/anionic phospholipid (molar 
ratio, 1:1) liposomes incubated with calcium chloride. (B) PC/anionic phospholipid (molar ratio, 1:1) liposomes incubated with 
gentamicin in the presence of 1 ~M calcium. (C) PC/anionic phospholipid (molar ratio, 1 : 1) liposomes incubated with gentamicin in 
the presence of 3 mM calcium. (D) PC/anionic phospholipid (molar ratio, 10:1) liposomes incubated with gentamicin in the 
presence of 1 #M calcium. Key: (zx) PC/PS; (n) PC/PI;  (A) PC/PIP; (m) PC/PIP2; ( ~ )  PC/PS, PC/PI  and PC/PIP. 
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intensity of ANS-treated liposomes were first 
measured in the presence of 1 ffM calcium which 
is a known competitor of aminoglycoside binding 
(Fig. 1B). This concentration of calcium ap- 
proximates intracellular levels and was considered 
appropriate since PIP 2 is believed to reside in the 
inner bilayers of cytoplasmic membranes [1]. 
Liposomes of all lipids tested showed varying 
degrees of reactivity towards the aminoglycoside 
and the PIP2-containing liposomes displayed the 
greatest increase in fluorescence. In the presence 
of excess calcium (3 mM), addition of gentamicin 
to the PIP2-enriched liposomes increased fluores- 
cence significantly even when the concentration of 
the antibiotic was two orders of magnitude lower 
than that of calcium (Fig. 1C). Liposomes contain- 
ing the other anionic phospholipids did not re- 
spond to the antibiotic at these calcium levels. 
Experiments without calcium yielded results iden- 
tical to those obtained in the presence of 1 ffM 
calcium. In all cases, addition of calcium and 
aminoglycosides did not significantly alter the 
emission spectrum or shift the maximum emission 
wavelength of ANS. 
When the ratio of PC to the anionic phos- 
pholipid was increased to 10:1 (Fig. 1D), lipo- 
somes containing PIP z still reacted with gentami- 
cin. Small increases in fluorescence were even 
noted for P C / P I P  2 liposomes with molar ratios as 
high as 15 : 1. In contrast, no increases in fluores- 
cence were seen for other acidic phospholipids at 
molar ratios of 8 : 1 (data not shown). 
Analysis of the dependence of fluorescence on 
the liposome concentration showed that the 
extrapolated maximal fluorescence of P C /P IP  2 
liposomes was unaffected by the aminoglycoside, 
gentamicin. This was also the case for amikacin, 
another aminoglycoside tested (Fig. 2A). With 
P C / H ,  aminoglycosides induced significantly 
smaller changes of fluorescence but maximal fluo- 
rescence again remained unchanged. 
Further quantitative analyses were performed 
for the binding parameters by a procedure similar 
to that described by Klotz [7]. If no interaction 
between the binding sites on the liposomes is 
assumed, the Klotz equation will take the form: 
xA o = n ( A o Z  XAo) 
where: 
t o = 
A o = 
X = 
n 
g d = 
the total liposome concentration; 
the total ANS concentration; 
the fraction of the ANS bound (calculated 
as the ratio of the fluorescence value and 
the reciprocal of the intercept of the dou- 
ble-reciprocal plots of fluorescence versus 
liposome concentration in the presence of a 
given concentration of ANS); 
the number of binding sites (moles/mole 
phospholipid); and 
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Fig. 2. (A) Double reciprocal plots of relative fluorescence against liposome concentration for P C / P I P  2 (molar ratio, 4 :1)  liposomes 
incubated with 10/~M ANS. (B) Double reciprocal plots of bound ANS against free ANS for P C / P I P  2 (molar ratio, 4: 1) liposomes 
(0.25 mM lipid) incubated with ANS. Key: (H) Control; (A) 0.1 mM amikacin; (11) 0.1 mM gentamicin. 
TABLE I 
EFFECT OF AMINOGLYCOSIDES ON THE BINDING 
OF ANS TO LIPOSOMES OF PC A N D  P C / A N I O N I C  
PHOSPHOLIPID (MOLAR RATIO, 4 :1)  
Liposome Aminoglycoside n (tool A N S /  K d (~M) 
composition mol PC) 
PC None 0.070 11.9 
P C / P I P  2 None 0.029 11.8 
Amikacin, 0.1 m M  0.043 11.8 
Gentamicin,  0.1 mM  0.063 12.1 
Gentamicin, 0.3 mM  0.068 11.8 
Gentamicin,  0.5 mM  0.070 12.1 
Gentamicin, 0.7 mM  0.071 11.9 
P C / P I  None 0.041 11.4 
Gentamicin,  0.1 mM 0.046 11.9 
Typical analyses are shown in Fig. 2B and the 
binding parameters (n and Kd) for PC, P C / P I P  2 
and PC/PI  liposomes in the absence and presence 
of aminoglycosides are summarized in Table I. In 
mixed liposomes, the number of ANS binding 
sites is lower than in pure PC liposomes. The 
addition of aminoglycoside, which does not affect 
PC liposomes, increases the number of ANS bind- 
ing sites (n) in these mixed liposomes but does not 
change the affinity of ANS to the lipid (K a). 
Discussion 
The effects of calcium and aminoglycosides on 
membrane structure as determined by the mem- 
brane probe, ANS, are in excellent agreement with 
the conclusions from our studies of surface pres- 
sure of monolayers and differential scanning 
calorimetry of liposomes [2,3]. Phosphatidylinosi- 
tol bisphosphate again was unique among the 
anionic lipids tested in its reactivity towards 
aminoglycosides. Even in the presence of calcium 
concentrations well above physiological signifi- 
cance and at ratios of ca lc ium/drug > 100, lipo- 
somes containing this lipid reacted with amino- 
glycosides. It also seems significant, in view of 
potential oto- and nephrotoxic mechanisms, that a 
drug interaction is observed at P C / P I P  2 ratios as 
low as 15:1 when other lipids were no longer 
reactive. 
Beyond the information obtained previously, 
this new model gives insight into the aminoglyco- 
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side-anionic phospholipid interaction at the 
molecular level. The increase in fluorescence by 
aminoglycosides could be due to changes in the 
molecular environment of the probe, in the affin- 
ity of the binding sites for ANS or in the number 
of binding sites available. The former effect would 
lead to a change in quantum yield of ANS while 
the latter two would lead to changes in the bind- 
ing parameters. 
The extrapolated maximum fluorescence of 
ANS in P C/P I  and P C / P I P  2 liposomes was the 
same and was unaffected by the addition of 
aminoglycosides (Fig. 2A). Thus, the drugs did not 
change the quantum yield (Q). The facts that 
neither the aminoglycosides or the nature of the 
acidic lipid caused a quantum yield change or a 
change in the ANS emission spectrum suggest that 
these alterations do not change the microenviron- 
ment of an individual ANS molecule bound to 
PC. This conclusion is further supported by the 
observation that neither the addition of an anionic 
lipid or an aminoglycoside affected the affinity of 
ANS for its binding site (Kd) (Table I). The 
constancy of both the K d and Q values in the 
presence and absence of an anionic lipid is in 
excellent agreement with the assumption that ANS 
binds mainly to L-a-phosphatidylcholine [8] both 
in the presence and absence of aminoglycoside. 
The increases in fluorescence of the P C/P I  and 
P C / P I P  2 liposomes upon treatment with different 
aminoglycosides were due entirely to increases in 
the number of ANS binding sites (Table I). ANS 
binds to phospholipids in the region of their polar 
head groups and the number of molecules bound 
is determined by the surface charge of the lipo- 
some [9-11] and inversely proportional to the 
magnitude of the negative membrane surface 
potential [12]. Charged phospholipids contribute 
little to ANS binding [13,14], but the presence of 
cations increases ANS fluorescence; trivalent 
cations are more effective than bivalent cations 
which in turn are more active than univalent ones 
[15,16]. Thus, reductions in the electrostatic surface 
potential facilitate the binding of ANS molecules 
to the liposome [16,17]. The differences in the 
number of binding sites in the PC, PC/PI  and 
P C / P I P  2 liposomes observed here (Table I) should 
reflect differences in the surface potentials intro- 
duced by the anionic lipids resulting in a masking 
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of the binding sites for ANS on PC. This agrees 
with the conclusion reached above that ANS 
binds to the same receptor site, i.e., the same lipid, 
in all the liposomal systems tested. 
Gentamicin increased by 117% the number of 
binding sites in P C / P I P  2 liposomes but only by 
12% in P C / P I  liposomes (Table I). Gentamicin 
was much more effective than an equivalent con- 
centration of amikacin. These results are con- 
sistent with our previous findings that related the 
degree of interaction of aminoglycosides with PIP 2 
to their ototoxicity [2]. The effects of aminoglyco- 
sides can not be explained on the basis of charge 
neutralization of the liposomes only. For example, 
netilmicin is far more effective than amikacin in 
neutralizing surface charge as measured by the 
zeta potential of P C / P I P  2 liposomes, but is less 
effective in increasing ANS fluorescence [6]. Fur- 
thermore, aminoglycoside effects with PIP 2 are 
seen at high calcium/low aminoglycoside concen- 
trations (ratio, 100:1) where the drug contribu- 
tion to charge neutralization should be negligible. 
Such an effect is not obtained when PI is used in 
place of PIP 2. Thus, it appears that the ability of 
the aminoglycosides to increase ANS fluorescence 
is dependent on a specific PIP2-aminoglycoside 
interaction. This may be the induction of phase 
separation and the creation of large domains rich 
in PC. By such a mechanism, the number of 
potential binding sites for ANS will increase as an 
environment of pure PC is created which is not 
masked by anionic phospholipid. This would ex- 
plain the fact that only the value of n (number of 
unscreened sites), but not the values of K d (affin- 
ity of the sites) and Q (reflecting the microen- 
vironment of the probe) are affected by the 
aminoglycosides. Finally, the postulate of amino- 
glycoside-induced phase separation is strengthened 
by the observation that exposure of the P C / P I P  2 
liposomes to higher concentrations of gentamicin 
(0.3-0.7 raM) results in a maximal n of 0.07, a 
value equal to the number of binding sites in pure 
PC liposomes (Table I). This interpretation is con- 
sistent with data obtained by differential scanning 
calorimetry which suggested the ability of 
aminoglycosides to induce phase separation in 
P C / P I P  2 liposomes [3]. 
These findings further support our hypothesis 
that the polar head group of phosphatidylinositol 
bisphosphate is a specific site of action for 
aminoglycosides. The perturbation of PIP2-con- 
taining membranes by aminoglycosides and the 
resulting changes in membrane structure and 
function therefore may play a crucial role in the 
ototoxicity and nephrotoxicity of these drugs. 
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